|Publication Type||Government Report|
|Source||Volume SMA16-4938 (2016)|
|Year of Publication||2016|
|Authors||Administration, Substance Abuse and|
|Selection||Grey literature; Mat and su disorders|
Gives an overview of data on the use of sublingual and transmucosal buprenorphine for the medication-assisted treatment of opioid use disorder. Discusses the implications of utilizing medication-assisted treatment a a recovery support.
|Additional||More about this reference|
|Note||This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.|